| Date | Form | Description | Docs | XBRL | Pages |
| 07/17/01 | DEF 14A | Definitive proxy statements |
|
18 | |
| 06/14/01 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
22 | |
| 06/13/01 | 8-K | Current report filing |
|
5 | |
| 03/19/01 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 02/01/01 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/29/01 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/09/01 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
6 | |
| 09/14/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/13/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/12/00 | DEF 14A | Definitive proxy statements |
|
24 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...